It might not be time to panic yet about Tilray, but there's likely a problem ahead.
Investors looking for another hemp play might consider Charlotte's Web Holdings, which deals in a range of CBD wellness products.
Tilray will not be cash flow positive for another 2-3 years - that's not quick enough progress for me given its $7 billion dollar capitalization.
Let's check out the charts and indicators for this so-called pot play.
Assessing Aurora and its peers, strictly on the numbers.
Peltz's addition should pacify a persistent critique of the company.
Aurora Cannabis' hiring of deal maker Nelson Peltz opens up a wealth of new possibilities for the Canadian pot company.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
The plan is for Peltz to help the firm in maximizing potential markets to target.